Identifying attack surfaces in the evolving space industry using reference architectures

The space environment is currently undergoing a substantial change and many new entrants to the market are deploying devices, satellites and systems in space; this evolution has been termed as NewSpace. The change is complicated by technological developments such as deploying machine learning based autonomous space systems and the Internet of Space Things (IoST). In the IoST, space systems will rely on satellite-to-x communication and interactions with wider aspects of the ground segment to a greater degree than existing systems. Such developments will inevitably lead to a change in the cyber security threat landscape of space systems. Inevitably, there will be a greater number of attack vectors for adversaries to exploit, and previously infeasible threats can be realised, and thus require mitigation. In this paper, we present a reference architecture (RA) that can be used to abstractly model in situ applications of this new space landscape. The RA specifies high-level system components and their interactions. By instantiating the RA for two scenarios we demonstrate how to analyse the attack surface using attack trees

Limited scope for group coordination in stylistic variations of kolam art

In large, complex societies, assorting with others with similar social norms or behaviors can facilitate successful coordination and cooperation. The ability to recognize others with shared norms or behaviors is thus assumed to be under selection. As a medium of communication, human art might reflect fitness-relevant information on shared norms and behaviors of other individuals thus facilitating successful coordination and cooperation.Distinctive styles or patterns of artistic design could signify migration history, different groups with a shared interaction history due to spatial proximity, as well as individual-level expertise and preferences. In addition, cultural boundaries may be even more pronounced in a highly diverse and socially stratified society. In the current study, we focus on a large corpus of an artistic tradition called kolam that is produced by women from Tamil Nadu in South India (N = 3,139 kolam drawings from 192 women) to test whether stylistic variations in art can be mapped onto caste boundaries, migration and neighborhoods. Since the kolam art system with its sequential drawing decisions can be described by a Markov process, we characterize variation in styles of art due to different facets of an artist's identity and the group affiliations, via hierarchical Bayesian statistical models.Our results reveal that stylistic variations in kolam art only weakly map onto caste boundaries, neighborhoods, and regional origin. In fact, stylistic variations or patterns in art are dominated by artist-level variation and artist expertise. Our results illustrate that although art can be a medium of communication, it is not necessarily marked by group affiliation. Rather, artistic behaviour in this context seems to be primarily a behavioral domain within which individuals carve out a unique niche for themselves to differentiate themselves from others. Our findings inform discussions on the evolutionary role of art for group coordination by encouraging researchers to use systematic methods to measure the mapping between specific objects or styles onto groups

Estimating the reproducibility of social learning research published between 1955 and 2018

Reproducibility is integral to science, but difficult to achieve. Previous research has quantified low rates of data availability and results reproducibility across the biological and behavioural sciences. Here, we surveyed 560 empirical publications, published between 1955 and 2018 in the social learning literature, a research topic that spans animal behaviour, behavioural ecology, cultural evolution and evolutionary psychology. Data were recoverable online or through direct data requests for 30% of this sample. Data recovery declines exponentially with time since publication, halving every 6 years, and up to every 9 years for human experimental data. When data for a publication can be recovered, we estimate a high probability of subsequent data usability (87%), analytical clarity (97%) and agreement of published results with reproduced findings (96%). This corresponds to an overall rate of recovering data and reproducing results of 23%, largely driven by the unavailability or incompleteness of data. We thus outline clear measures to improve the reproducibility of research on the ecology and evolution of social behaviour

The Classification of Obsessive–Compulsive and Related Disorders in the ICD-11

Background To present the rationale for the new Obsessive–Compulsive and Related Disorders (OCRD) grouping in the Mental and Behavioural Disorders chapter of the Eleventh Revision of the World Health Organization’s International Classification of Diseases and Related Health Problems (ICD-11), including the conceptualization and essential features of disorders in this grouping. Methods Review of the recommendations of the ICD-11 Working Group on the Classification for OCRD. These sought to maximize clinical utility, global applicability, and scientific validity. Results The rationale for the grouping is based on common clinical features of included disorders including repetitive unwanted thoughts and associated behaviours, and is supported by emerging evidence from imaging, neurochemical, and genetic studies. The proposed grouping includes obsessive–compulsive disorder, body dysmorphic disorder, hypochondriasis, olfactory reference disorder, and hoarding disorder. Body-focused repetitive behaviour disorders, including trichotillomania and excoriation disorder are also included. Tourette disorder, a neurological disorder in ICD-11, and personality disorder with anankastic features, a personality disorder in ICD-11, are recommended for cross-referencing. Limitations Alternative nosological conceptualizations have been described in the literature and have some merit and empirical basis. Further work is needed to determine whether the proposed ICD-11 OCRD grouping and diagnostic guidelines are mostly likely to achieve the goals of maximizing clinical utility and global applicability. Conclusion It is anticipated that creation of an OCRD grouping will contribute to accurate identification and appropriate treatment of affected patients as well as research efforts aimed at improving our understanding of the prevalence, assessment, and management of its constituent disorders

Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial

Altered histone deacetylase (HDAC) activity has been identified in several types of cancer. This study was designed to determine the safety and maximum tolerated dose (MTD) of valproic acid (VPA) as an HDAC inhibitor in cancer patients. Twenty-six pre-treated patients with progressing solid tumours were enrolled in dose-escalating three-patient cohorts, starting at a dose of VPA 30 mg kg−1 day−1. VPA was administered as an 1-h infusion daily for 5 consecutive days in a 21-day cycle. Neurocognitive impairment dominated the toxicity profile, with grade 3 or 4 neurological side effects occurring in 8 out of 26 patients. No grade 3 or 4 haematological toxicity was observed. The MTD of infusional VPA was 60 mg kg−1 day−1. Biomonitoring of peripheral blood lymphocytes demonstrated the induction of histone hyperacetylation in the majority of patients and downmodulation of HDAC2. Pharmacokinetic studies showed increased mean and maximum serum VPA concentrations >120 and >250 mg l−1, respectively, in the 90 and 120 mg kg−1 cohorts, correlating well with the incidence of dose-limiting toxicity (DLT). Neurotoxicity was the main DLT of infusional VPA, doses up to 60 mg kg−1 day−1 for 5 consecutive days are well tolerated and show detectable biological activity. Further investigations are warranted to evaluate the effectivity of VPA alone and in combination with other cytotoxic drugs

Electronic structure of β-Si3N4 crystals with substitutional icosagen group impurities

The β-Si3N4 crystals are widely used in industrial and electronics areas. Therefore, β-Si3N4 has drawn the attention of researchers for many years. In this study, effects of icosagen group impurity atoms in the IIIA group on the electronic properties of the β-Si3N4 crystal were analyzed by using the density functional theory. As a result of these analyses, it was determined that the electronic properties of the crystal change significantly. Basic electronic characteristics for pure β-Si3N4 crystal and icosagen group impurity β-Si3N4 crystals, such as band structures, densities of states, binding energies, and formation energies were investigated. We identified that the band gap of the β-Si3N4 crystal was affected significantly by the impurity, and this change was varying linearly in line with the formation energy for the impurity cases. As a result of calculations, the Al-impurity was found to be the lowest-energy impurity state

Third-Line Nivolumab Monotherapy in Recurrent Small Cell Lung Cancer : CheckMate 032

Introduction: For patients with recurrent SCLC, topotecan remains the only approved second-line treatment, and the outcomes are poor. CheckMate 032 is a phase 1/2, multicenter, open-label study of nivolumab or nivolumab plus ipilimumab in SCLC or other advanced/metastatic solid tumors previously treated with one or more platinum-based chemotherapies. We report results of third- or later-line nivolumab monotherapy treatment in SCLC. Methods: In this analysis, patients with limited-stage or extensive-stage SCLC and disease progression after two or more chemotherapy regimens received nivolumab monotherapy, 3 mg/kg every 2 weeks, until disease progression or unacceptable toxicity. The primary end point was objective response rate. Secondary end points included duration of response, progression-free survival, overall survival, and safety. Results: Between December 4, 2013, and November 30, 2016, 109 patients began receiving third- or later-line nivolumab monotherapy. At a median follow-up of 28.3 months (from first dose to database lock), the objective response rate was 11.9% (95% confidence interval: 6.5\u201319.5) with a median duration of response of 17.9 months (range 3.0\u201342.1). At 6 months, 17.2% of patients were progression-free. The 12-month and 18-month overall survival rates were 28.3% and 20.0%, respectively. Grade 3 to 4 treatment-related adverse events occurred in 11.9% of patients. Three patients (2.8%) discontinued because of treatment-related adverse events. Conclusions: Nivolumab monotherapy provided durable responses and was well tolerated as a third- or later-line treatment for recurrent SCLC. These results suggest that nivolumab monotherapy is an effective third- or later-line treatment for this patient population